18F-FDG PET has been shown to effectively detect differentiated thyroid carcinoma (DTC)
metastases with impaired iodine-trapping ability. This article evaluates the potential …

FDG PET is increasingly performed in patients with differentiated thyroid cancer who present
with elevated human thyroglobulin (hTG) levels and negative 131I scan. The aim of this …

Background Exact localization of recurrent iodine-negative thyroid cancer is mandatory,
since surgery is the only curative therapy option in patients with iodine-negative tumor …

PET using 18F-FDG has been shown to effectively detect various types of cancer by their
increased glucose metabolism. The aim of this study was to evaluate the use of coregistered …

Metastases of differentiated thyroid cancer may show different uptake patterns for fluorine-18
fluorodeoxyglucose and [131 I] NaI. FDG positron emission tomography (PET), iodine-131 …

There are several reports about the usefulness of 18F-FDG PET in thyroid cancer. However,
few studies have compared FDG PET with 131I and 201Tl scintigraphy. The aim of this study …

Abstract Aims 18 F-FDG PET/CT is the most accurate imaging modality in differentiated
thyroid cancer (DTC) patients with either an aggressive histology, an absence of radioiodine …

Purpose: There are approximately 32,000 new cases of thyroid carcinoma annually in the
United States. F-18 FDG PET/CT has an established role in cancer management, including …

Purpose Advanced tumour stage and initial metastases are associated with reduced general
and tumour-free survival in patients with differentiated thyroid carcinoma. Optimal initial …

Aims This study aimed (a) to determine the clinical and histopathologic factors that are
related to FDG avidity in the recurrence/metastases of patients with differentiated thyroid …